Addressing communication gaps between physicians, in-home nurses

Efficient communication is key in providing quality care to patients. But according to a new study published in the Journal of General Internal Medicine, communication between physicians and home healthcare (HHC) agencies has major gaps. This gap, mainly concerning the care of elderly patients discharged from hospitals, could increase readmission rates.

Led by Christine D. Jones, MD, MS, assistant professor at the University of Colorado School of Medicine, researchers at the University of Colorado Anschutz Medical Campus reported discrepancies in medication lists, confusion on who writes patient care orders, inaccessibility to health records and low rates of accountability as factors negatively effecting communication.

"We found that communication breakdowns can have consequences for patients," said Jones. "These are some of our most fragile patients, most are over 65, and more seamless communication is needed. As hospitalists, we need to think about what happens beyond the hospital walls and how we can support our patients after discharge, especially when it comes to home healthcare patients who can be very vulnerable.”

Researchers noted the following possible solutions to fix the communication gap and improve patient care:

  • Provide HHC agencies access to electronic health records and phone lines to doctors.
  • Put laws in place allowing nurse practitioner and physician’s assistants to write HHC orders.
  • Clearly establish accountability for hospital clinicians to manage HHC orders until a primary care physician can attend to the patient and answer questions.
  • Develop more effective communication methods with primary care physicians for more secure transitions.

"Our findings suggest that improvements to accountability and communication could address patient needs and goals, avoid medication discrepancies and ultimately improve safety for patients and HHC nurses," said Jones.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.